Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Monday, May 7, 2007
Today's Globe: all things BIO, disease and deployments, 'no' to drug money, Alzheimer's target, gene music, diet pill
Partiers get down to business at the BIO convention, while a rally in opposition to a high-security research laboratory now under construction at Boston University Medical Center fell far short of the mass demonstrations that some had predicted. On the op-ed page, Jerry Avorn urges rethinking research funding, Edward L. Glaeser suggests embracing biotechnology and Joshua Boger recommends building a system of outreach and collaboration.
A parasitic disease rarely seen in United States but common in the Middle East has infected an estimated 2,500 US troops in the last four years because of massive deployments to remote combat zones in Iraq and Afghanistan, military officials said. And four types of bacteria are causing severe and hard-to-treat infections for many troops wounded there.
There are names for what Dr. Daniel J. Carlat (left) once was, and he does not hesitate to use them: "Drug whore," he suggested calmly. "Hired gun." Now he says 'no' to drug money and wants to limit corporate sway over psychiatry.
Most of the drugs being tested to treat or prevent Alzheimer's disease target proteins called beta amyloid, which accumulate in the brain and are suspected as a cause of the devastating dementia. But new research in mice suggests another treatment approach -- reducing levels of a protein called tau.
The Musical Gene Expression project at Harvard Medical School envisions a future where doctors will be able to tune in to the internal music of their patients.
Also in Health/Science, meet radiologist Nobuhiko Hata, a radiologist who invents new technologies for use in surgery, and consider whether virtual colon cancer screenings are ready for real-world usage.
In Business, Alli, the nation's first over-the-counter diet remedy approved by the Food and Drug Administration, goes on sale within weeks.